Sandoz Inc recalls Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare C
Recalled November 16, 2016 · FDA recall D-0133-2017 · Sandoz
Hazard
Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application. · FDA Class II
Units
42,740 cartons (24 count carton from 7 total lots)
Sold at
TN
Description
Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.
Product
Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054
Manufacturer(s)
Sandoz Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →